EGFR and non-small cell lung carcinoma: A similar approach could be used to interrogate TCGA data for the predictive value of immune profiles and T-cell infiltration for other monoclonal antibody therapies such as cetuximab in EGFR-mutated non-small cell lung cancer patients38.